Browse Arkansas Code titles and sections
42 U.S.C. § 6992a — Listing of medical wastes
Federal law — U.S. Code and appendices · legal_authorities
Page 7040
TITLE 42—THE PUBLIC HEALTH AND WELFARE
§ 6992
1 So in original. Probably should be ‘‘exudates’’.
SUBCHAPTER X—DEMONSTRATION
MEDICAL WASTE TRACKING PROGRAM
§ 6992. Scope of demonstration program for med-
ical waste
(a) Covered States
The States within the demonstration program
established under this subchapter for tracking
medical wastes shall be New York, New Jersey,
Connecticut, the States contiguous to the Great
Lakes and any State included in the program
through the petition procedure described in sub-
section (c), except for any of such States in
which the Governor notifies the Administrator
under subsection (b) that such State shall not be
covered by the program.
(b) Opt out
(1) If the Governor of any State covered under
subsection (a) which is not contiguous to the At-
lantic Ocean notifies the Administrator that
such State elects not to participate in the dem-
onstration program, the Administrator shall re-
move such State from the program.
(2) If the Governor of any other State covered
under subsection (a) notifies the Administrator
that such State has implemented a medical
waste tracking program that is no less stringent
than the demonstration program under this sub-
chapter and that such State elects not to par-
ticipate in the demonstration program, the Ad-
ministrator shall, if the Administrator deter-
mines that such State program is no less strin-
gent than the demonstration program under this
subchapter, remove such State from the dem-
onstration program.
(3) Notifications under paragraphs (1) or (2)
shall be submitted to the Administrator no later
than 30 days after the promulgation of regula-
tions implementing the demonstration program
under this subchapter.
(c) Petition in
The Governor of any State may petition t
Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 6992a
Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: c46930a22f1813403cb2ddfe93c77c1e0c0daa99b37e3b5b6c4fb6b72cd19f61. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:usc2024-6d0d2d424ee4245079deb635
Source file: Laws/federal/codes/united-states-code-2024/title-42/section-6992a-listing-of-medical-wastes--eb96674b0f.md
Pages: Not recorded – Not recorded
Passage SHA-256: c91850b92a193e8956dbbd92800020832f359b8c80d063159c90e56e19070bf8
Source location: USCODE-2024-title42-chap82-subchapX-sec6992a.pdf
Stored source content
Page 7040
TITLE 42—THE PUBLIC HEALTH AND WELFARE
§ 6992
1 So in original. Probably should be ‘‘exudates’’.
SUBCHAPTER X—DEMONSTRATION
MEDICAL WASTE TRACKING PROGRAM
§ 6992. Scope of demonstration program for med-
ical waste
(a) Covered States
The States within the demonstration program
established under this subchapter for tracking
medical wastes shall be New York, New Jersey,
Connecticut, the States contiguous to the Great
Lakes and any State included in the program
through the petition procedure described in sub-
section (c), except for any of such States in
which the Governor notifies the Administrator
under subsection (b) that such State shall not be
covered by the program.
(b) Opt out
(1) If the Governor of any State covered under
subsection (a) which is not contiguous to the At-
lantic Ocean notifies the Administrator that
such State elects not to participate in the dem-
onstration program, the Administrator shall re-
move such State from the program.
(2) If the Governor of any other State covered
under subsection (a) notifies the Administrator
that such State has implemented a medical
waste tracking program that is no less stringent
than the demonstration program under this sub-
chapter and that such State elects not to par-
ticipate in the demonstration program, the Ad-
ministrator shall, if the Administrator deter-
mines that such State program is no less strin-
gent than the demonstration program under this
subchapter, remove such State from the dem-
onstration program.
(3) Notifications under paragraphs (1) or (2)
shall be submitted to the Administrator no later
than 30 days after the promulgation of regula-
tions implementing the demonstration program
under this subchapter.
(c) Petition in
The Governor of any State may petition the
Administrator to be included in the demonstra-
tion program and the Administrator may, in his
discretion, include any such State. Such peti-
tion may not be made later than 30 days after
promulgation of regulations establishing the
demonstration program under this subchapter,
and the Administrator shall determine whether
to include the State within 30 days after receipt
of the State’s petition.
(d) Expiration of demonstration program
The demonstration program shall expire on
the date 24 months after the effective date of the
regulations under this subchapter.
(Pub. L. 89–272, title II, § 11001, as added Pub. L.
100–582, § 2(a), Nov. 1, 1988, 102 Stat. 2950.)
§ 6992a. Listing of medical wastes
(a) List
Not later than 6 months after November 1,
1988, the Administrator shall promulgate regula-
tions listing the types of medical waste to be
tracked under the demonstration program. Ex-
cept as provided in subsection (b), such list shall
include, but need not be limited to, each of the
following types of solid waste:
(1) Cultures and stocks of infectious agents
and associated biologicals, including cultures
from medical and pathological laboratories,
cultures and stocks of infectious agents from
research and industrial laboratories, wastes
from the production of biologicals, discarded
live and attenuated vaccines, and culture
dishes and devices used to transfer, inoculate,
and mix cultures.
(2) Pathological wastes, including tissues,
organs, and body parts that are removed dur-
ing surgery or autopsy.
(3) Waste human blood and products of
blood, including serum, plasma, and other
blood components.
(4) Sharps that have been used in patient
care or in medical, research, or industrial lab-
oratories, including hypodermic needles, sy-
ringes, pasteur pipettes, broken glass, and
scalpel blades.
(5) Contaminated animal carcasses, body
parts, and bedding of animals that were ex-
posed to infectious agents during research,
production of biologicals, or testing of phar-
maceuticals.
(6) Wastes from surgery or autopsy that were
in contact with infectious agents, including
soiled dressings, sponges, drapes, lavage tubes,
drainage sets, underpads, and surgical gloves.
(7) Laboratory wastes from medical, patho-
logical, pharmaceutical, or other research,
commercial, or industrial laboratories that
were in contact with infectious agents, includ-
ing slides and cover slips, disposable gloves,
laboratory coats, and aprons.
(8) Dialysis wastes that were in contact with
the blood of patients undergoing hemodialysis,
including contaminated disposable equipment
and supplies such as tubing, filters, disposable
sheets, towels, gloves, aprons, and laboratory
coats.
(9) Discarded medical equipment and parts
that were in contact with infectious agents.
(10) Biological waste and discarded materials
contaminated
with
blood,
excretion,
excudates 1 or secretion from human beings or
animals who are isolated to protect others
from communicable diseases.
(11) Such other waste material that results
from the administration of medical care to a
patient by a health care provider and is found
by the Administrator to pose a threat to
human health or the environment.
(b) Exclusions from list
The Administrator may exclude from the list
under this section any categories or items de-
scribed in paragraphs (6) through (10) of sub-
section (a) which he determines do not pose a
substantial present or potential hazard to
human health or the environment when improp-
erly treated, stored, transported, disposed of, or
otherwise managed.
(Pub. L. 89–272, title II, § 11002, as added Pub. L.
100–582, § 2(a), Nov. 1, 1988, 102 Stat. 2951.)
§ 6992b. Tracking of medical waste
(a) Demonstration program
Not later than 6 months after November 1,
1988, the Administrator shall promulgate regula-
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
**(a) List** Not later than 6 months after November 1, 1988, the Administrator shall promulgate regulations listing the types of medical waste to be tracked under the demonstration program. Except as provided in subsection (b), such list shall include, but need not be limited to, each of the following types of solid waste:
(1) Cultures and stocks of infectious agents and associated biologicals, including cultures from medical and pathological laboratories, cultures and stocks of infectious agents from research and industrial laboratories, wastes from the production of biologicals, discarded live and attenuated vaccines, and culture dishes and devices used to transfer, inoculate, and mix cultures.
(2) Pathological wastes, including tissues, organs, and body parts that are removed during surgery or autopsy.
(3) Waste human blood and products of blood, including serum, plasma, and other blood components.
(4) Sharps that have been used in patient care or in medical, research, or industrial laboratories, including hypodermic needles, syringes, pasteur pipettes, broken glass, and scalpel blades.
(5) Contaminated animal carcasses, body parts, and bedding of animals that were exposed to infectious agents during research, production of biologicals, or testing of pharmaceuticals.
(6) Wastes from surgery or autopsy that were in contact with infectious agents, including soiled dressings, sponges, drapes, lavage tubes, drainage sets, underpads, and surgical gloves.
(7) Laboratory wastes from medical, pathological, pharmaceutical, or other research, commercial, or industrial laboratories that were in contact with infectious agents, including slides and cover slips, disposable gloves, laboratory coats, and aprons.
(8) Dialysis wastes that were in contact with the blood of pati
Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 6992a
Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.